People · Operator

Gwill York

Named in public records as an officer, director or promoter · active 2019–2023 · Biotechnology

1
Companies
4
Filings
$193.9M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Alto Neuroscience, Inc.BiotechnologySeries C$193.9M$270.8M2019
Operator network

Gwill York at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Michael Hanley · 5 companies · 1 sharedMichael HanleyNicholas Smith · 5 companies · 1 sharedNicholas SmithAaron Weaver · 3 companies · 1 sharedAaron WeaverAdam Savitz · 1 companies · 1 sharedAdam SavitzAmit Etkin · 1 companies · 1 sharedAmit EtkinAndrew Nixon Dreyfus · 1 companies · 1 sharedAndrew Nixon Drey…Chris Nixon Dimitropoulos · 1 companies · 1 sharedChris Nixon Dimit…Christopher Nixon Cox · 1 companies · 1 sharedChristopher Nixon…Gwill C. York · 1 companies · 1 sharedGwill C. YorkHusseini Nixon Manji · 1 companies · 1 sharedHusseini Nixon Ma…Michael Nixon Liang · 1 companies · 1 sharedMichael Nixon Lia…Nicholas C. Smith · 1 companies · 1 sharedNicholas C. SmithPo Yu (Jeff) Chen · 1 companies · 1 sharedPo Yu (Jeff) ChenRaymond Nixon Sanchez · 1 companies · 1 sharedRaymond Nixon San…Alto Neuroscience, Inc. · $193.9M raisedAlto Neuroscience, In…Gwill YorkGY
Gwill York Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Gwill York on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Michael Hanley15
Nicholas Smith15
Aaron Weaver13
Gwill C. York11
Husseini Nixon Manji11
Christopher Nixon Cox11
Raymond Nixon Sanchez11
Adam Savitz11
Michael Nixon Liang11
Po Yu (Jeff) Chen11
Chris Nixon Dimitropoulos11
Andrew Nixon Dreyfus11
Amit Etkin11
Nicholas C. Smith11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.